SEC Info - Northrop Grumman Corp/DE - ‘8-K’ for 3/19/20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

i March 19, 2020

NORTHROP GRUMMAN CORPORATION

(Exact name of registrant as specified in its charter)

i Delaware

i 1-16411

No. i 80-0640649

(State or Other Jurisdiction of

Incorporation or Organization)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

i 2980 Fairview Park Drive, i Falls Church, i Virginia i 22042

(Address of principal executive offices)(Zip Code)

i (703) i 280-2900

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

i Common Stock

i NOC

i New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01

Entry into a Material Definitive Agreement.

On March 23, 2020, Northrop Grumman Corporation (the “Company”) issued $750,000,000 in aggregate principal amount of 4.400% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 in aggregate principal amount of 5.150% Senior Notes due 2040 (the “2040 Notes”) and $1,000,000,000 in aggregate principal amount of 5.250% Senior Notes due 2050 (the “2050 Notes” and, together with the 2030 Notes and the 2040 Notes, the “Notes”). The Notes were issued pursuant to an indenture (the “Original Indenture”), dated as of November 21, 2001, as supplemented by the first supplemental indenture, dated as of July 30, 2009 (the “First Supplemental Indenture”), the third supplemental indenture, dated as of March 30, 2011 (the “Third Supplemental Indenture”), the fourth supplemental indenture, dated as of March 30, 2011 (the “Fourth Supplemental Indenture”) and the ninth supplemental indenture, dated as of March 23, 2020 (the “Ninth Supplemental Indenture”) between the Company and The Bank of New York Mellon (the “Trustee”) (the Original Indenture as supplemented by the First Supplemental Indenture, the Third Supplemental Indenture, the Fourth Supplemental Indenture and the Ninth Supplemental Indenture, the “Indenture”). The Notes were sold pursuant to an Underwriting Agreement, dated March 19, 2020, by and among the Company and J.P. Morgan Securities LLC, BofA Securities, Inc. and Citigroup Global Markets Inc., as representatives of the several underwriters named therein.

The 2030 Notes will mature on May 1, 2030, the 2040 Notes will mature on May 1, 2040 and the 2050 Notes will mature on May 1, 2050, in each case, unless redeemed earlier. The Company may redeem any of the series of notes at its option, as a whole or in part, at any time or from time to time, at the redemption prices described in the Final Prospectus Supplement filed with the Securities and Exchange Commission dated March 19, 2020.

The Indenture governing the Notes contains certain covenants, including covenants related to our ability to create liens, engage in certain sale and leaseback transactions and engage in certain transactions and asset sales. These covenants are subject to exceptions and qualifications.

The terms and conditions of the Notes are set forth in the Original Indenture, filed as an exhibit to the Company’s current report on Form 8-K filed on November 21, 2001, the First Supplemental Indenture, filed as an exhibit to the Company’s current report on Form 8-K filed on July 30, 2009, the Third Supplemental Indenture, filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2011, filed on April 27, 2011, the Fourth Supplemental Indenture, filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2011, filed on April 27, 2011, and the Ninth Supplemental Indenture attached hereto as Exhibit 4.1. The foregoing description of the Notes and the Indenture is qualified in its entirety by reference to these documents. The Company has on file with the Securities and Exchange Commission an effective registration statement on Form S-3 dated March 31, 2017 (Registration No. 333-217087, the “Registration Statement”) and incorporates by reference the exhibits filed with this report into the Registration Statement.

Item 2.03

Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

The information in Item 1.01 is incorporated herein by reference.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits


Exhibit No.		Description

	1.1	Underwriting Agreement, dated March 19, 2020, among Northrop Grumman Corporation and J.P. Morgan Securities LLC, BofA Securities, Inc. and Citigroup Global Markets Inc., as representatives of the several underwriters named therein

	4.1	Ninth Supplemental Indenture, dated as of March 23, 2020, between Northrop Grumman Corporation and The Bank of New York Mellon, as successor to JPMorgan Chase Bank, Trustee, to Indenture dated as of November 21, 2001

	4.2	Form of 4.400% Senior Note due 2030 (included in Exhibit 4.1)

	4.3	Form of 5.150% Senior Note due 2040 (included in Exhibit 4.1)

	4.4	Form of 5.250% Senior Note due 2050 (included in Exhibit 4.1)

	5.1	Opinion of Cravath, Swaine & Moore LLP

	23.1	Consent of Cravath, Swaine & Moore LLP (included in Exhibit 5.1)

	104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


NORTHROP GRUMMAN CORPORATION
(Registrant)

By:		/s/ *Jennifer C. McGarey*
		Jennifer C. McGarey
		Corporate Vice President and Secretary

Date: March 23, 2020

This ‘8-K’ Filing	Date	Other Filings

	5/1/30
Filed as of:	3/24/20
Filed on:	3/23/20	424B5
For Period end:	3/19/20	424B5, 8-K
	3/31/17	10-Q, 4, DEF 14A, S-3ASR
	4/27/11	10-Q, 8-K
	3/31/11	10-Q, 4
	3/30/11	4, 4/A
	7/30/09	4/A, 8-K
	11/21/01	8-K
		List all Filings

Northrop Grumman Corp/DE – ‘8-K’ for 3/19/20

On: Monday, 3/23/20, at 8:19pm ET · As of: 3/24/20 · For: 3/19/20 · Accession #: 1193125-20-82921 · File #: 1-16411

Previous ‘8-K’: ‘8-K’ on 3/20/20 for 3/19/20 · Next: ‘8-K’ on / for 4/29/20 · Latest: ‘8-K’ on / for 4/25/24 · 7 References:

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

7 Subsequent Filings that Reference this Filing